Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab von Beulque, Yana, Kinget, Lisa, Roussel, Eduard, Mobaraki, Sajedeh, Laenen, Annouschka, Debruyne, Philip R, Van Herck, Yannick, Baldewijns, Marcella, Wozniak, Agnieszka, Garg, Abhishek D, Zucman-Rossi, Jessica, Couchy, Gabrielle, Albersen, Maarten, De Wever, Liesbeth, Haaker, Lorenz, Beuselinck, Benoit

Volltext

Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab von Beulque, Yana, Kinget, Lisa, Roussel, Eduard, Mobaraki, Sajedeh, Laenen, Annouschka, Debruyne, Philip R, Van Herck, Yannick, Baldewijns, Marcella, Wozniak, Agnieszka, Garg, Abhishek D, Zucman-Rossi, Jessica, Couchy, Gabrielle, Albersen, Maarten, De Wever, Liesbeth, Haaker, Lorenz, Beuselinck, Benoit

Volltext

Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A128 Polymorphism von Mobaraki, Sajedeh, Nissen, Peter Henrik, Donskov, Frede, Wozniak, Agnieszka, Van Herck, Yannick, Coosemans, Lina, van Nieuwenhuyse, Tine, Lambrechts, Diether, Bechter, Oliver, Baldewijns, Marcella, Roussel, Eduard, Laenen, Annouschka, Beuselinck, Benoit

Volltext

Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A128 Polymorphism von Mobaraki, Sajedeh, Nissen, Peter Henrik, Donskov, Frede, Wozniak, Agnieszka, Van Herck, Yannick, Coosemans, Lina, van Nieuwenhuyse, Tine, Lambrechts, Diether, Bechter, Oliver, Baldewijns, Marcella, Roussel, Eduard, Laenen, Annouschka, Beuselinck, Benoit

Volltext